The Smoking Cessation Leadership Center and Legacy to bring a free webinar offering, “Menthol – Science, Policy, and Advocacy,” on Thursday, May 5, 2011, at 1:00 pm Eastern Time (90 minutes). The issue of menthol in tobacco products is at the forefront of FDA deliberations. Join the webinar to learn about the science of menthol and its implications for policy and advocacy.
The experts in tobacco control on the webinar panel: David Abrams, Ph.D., Executive Director of the Schroeder Institute at Legacy; Ellen Vargyas, J.D, General Counsel Member and Corporate Secretary, Legacy; Amber Thornton-Bullock, Executive Vice President of Program Development, Legacy
Webinar objectives:
• Learn the science behind the Tobacco Products Scientific Advisory Committee's (TPSAC) recommendation to the FDA that "removal of menthol cigarettes from the marketplace would benefit public health in the United States."
• Learn about policies already in place and under development that address concerns about menthol.
• Understand the impact of these policies on tobacco control.
• Discuss key messages about the needs of tobacco dependent treatment for disparate populations.
Register now using the following link and save the date. https://rwjf.webex.com/
Please feel free to forward this announcement to your colleagues. This free webinar will be recorded and can be viewed online on the Smoking Cessation Leadership Center’s website beginning May 6, 2011. For answers to other questions, contact Reason Reyes, SCLC director of technical assistance, at reason.reyes@ucsf.edu, or call toll-free (877) 509-3786.